Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

646
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
646
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

1.9K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Botulinum toxin A and neuropathic pain: An update.

Toxicon : official journal of the International Society on Toxinology·2023
Same author

[The 869C>T And 915G>C Polymorphisms of TGF-β1 and Type 1 Diabetic Retinopathy in the Algerian Population].

Journal francais d'ophtalmologie·2022
Same author

The descending pain modulation system predicts short term efficacy of multimodal pain therapy: an observational prospective cohort study.

Postgraduate medicine·2021
Same author

French guidelines for neuropathic pain: An update and commentary.

Revue neurologique·2021
Same author

Spinal cord injury pain.

Revue neurologique·2020
Same author

Central Nervous System Targets: Supraspinal Mechanisms of Analgesia.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2020

Related Experiment Video

Updated: Mar 24, 2026

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

1.6K

Neuropathic low back pain in clinical practice.

R Baron1, A Binder1, N Attal2

  • 1Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.

European Journal of Pain (London, England)
|March 4, 2016
PubMed
Summary

Neuropathic mechanisms are often under-recognized in chronic low back pain (LBP). New treatments like tapentadol and topical agents show promise for managing this challenging pain component.

More Related Videos

Manual Therapy for a Chronic Non-Specific Low Back Pain Rat Model
07:34

Manual Therapy for a Chronic Non-Specific Low Back Pain Rat Model

Published on: August 11, 2023

1.2K
Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain
05:10

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Published on: August 30, 2022

3.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

1.6K
Manual Therapy for a Chronic Non-Specific Low Back Pain Rat Model
07:34

Manual Therapy for a Chronic Non-Specific Low Back Pain Rat Model

Published on: August 11, 2023

1.2K
Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain
05:10

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Published on: August 30, 2022

3.6K

Area of Science:

  • Pain Medicine
  • Neurology
  • Pharmacology

Background:

  • Low back pain (LBP) is a prevalent chronic pain condition.
  • Neuropathic mechanisms in LBP are frequently under-recognized and undertreated.
  • Current treatments for LBP often fail to address the neuropathic component effectively.

Purpose of the Study:

  • To review the literature on neuropathic mechanisms in chronic LBP.
  • To discuss the implications for clinical management, focusing on pharmacological treatments.
  • To identify effective treatment options for the neuropathic component of LBP.

Main Methods:

  • Conducted literature searches in PubMed, key pain congresses, and ProQuest Dialog.
  • Assessed all titles for relevant published evidence on neuropathic back pain and its management.
  • Focused on identifying studies related to pharmacological interventions.

Main Results:

  • Chronic LBP involves both nociceptive and neuropathic pain.
  • Many LBP patients are refractory to existing treatments, with limited efficacy and adverse effects from oral pharmacotherapies.
  • Tapentadol, capsaicin 8% patch, and lidocaine 5% medicated plaster show potential for treating the neuropathic component of LBP.

Conclusions:

  • Chronic LBP frequently includes an under-recognized neuropathic component requiring better diagnosis and treatment.
  • Improved understanding of neuropathic LBP can lead to mechanism-based therapies.
  • Tapentadol and topical analgesics represent potential effective options for specific patient groups with neuropathic LBP.